Charitable trust registration requires a specified-violation notice; settled cash deposits and related-party payments did not justify cancellation or ...
External development charges trigger TDS under section 194C, while disputed administrative payments require factual verification and fresh adjudicatio...
Section 270AA penalty immunity requires identified statutory defaults and a hearing before rejection; reassessment disclosure may constitute under-rep...
Section 80JJAA employee-cost deduction allowed for deployed staff but barred against transfer-pricing income enhancement, with pricing issues remanded...
Transfer-pricing methodology protects commercially genuine associated-enterprise payments, while pre-2016 secondary adjustments and related notional i...
Negative liens over operating assets can constitute international transactions requiring arm's-length pricing reflecting restricted borrowing and expa...
Cross-examination rights in Customs Broker revocation inquiries require witness examination; procedural denial may be cured through fresh adjudication...
The case involved the classification of the product "Liv 52 Protec" as either an 'Animal Feed Supplement' or an 'Ayurvedic Medicament' under Central Excise Tariff Act. The Tribunal held that the product should be classified under Chapter Heading 3004 as an Ayurvedic medicament, not as an animal feed supplement under Chapter Heading 2309. The product's ingredients and properties supported its classification as an Ayurvedic medicament. The extended period for duty demand was deemed inapplicable as the appellant had disclosed all relevant information. Penalties under Section 11AC and Rule 25 of Central Excise Rules were dropped due to the classification issue. The appeal was disposed of partly in favor of the appellant.
The case involved the classification of the product "Liv 52 Protec" as either an 'Animal Feed Supplement' or an 'Ayurvedic Medicament' under Central Excise Tariff Act. The Tribunal held that the product should be classified under Chapter Heading 3004 as an Ayurvedic medicament, not as an animal feed supplement under Chapter Heading 2309. The product's ingredients and properties supported its classification as an Ayurvedic medicament. The extended period for duty demand was deemed inapplicable as the appellant had disclosed all relevant information. Penalties under Section 11AC and Rule 25 of Central Excise Rules were dropped due to the classification issue. The appeal was disposed of partly in favor of the appellant.
Note: It is a system-generated summary and is for quick reference only.